Post-Transplant Lymphoproliferative Disease clinical trials at UC Davis

1 research study open to eligible people

Tabelecleucel in Participants With Epstein-barr Virus (EBV)-Associated Diseases
open to all eligible people
The purpose of this study is to assess the efficacy and safety of tabelecleucel in participants with EBV-associated diseases.
Sacramento 5389489, California 5332921 and other locations

Last updated: August 21, 2025